BTF3P10

Across TCGA pan-cancer cohorts, BTF3P10 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of BTF3P10’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where BTF3P10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BTF3P10 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.

COAD, LUAD, and STAD are the cancer types where BTF3P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BTF3P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.641	<.001	6	view →
LUAD	Male	II,III,IV	+0.413	<.001	6	view →
STAD	All	All	−0.322	.034	4	view →
KIRC	All	All	+0.120	<.001	3	view →
READ	All	All	+0.473	.021	2	view →
THCA	Male	All	−0.228	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

BTF3P10–COAD

Open the COAD breakdown →